Stock PROGENICS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Progenics Pharmaceuticals, Inc.

Equities

US7431871067

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Perspective Therapeutics, Inc. completed the acquisition of Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey from Progenics Pharmaceuticals, Inc.
CI
Perspective Therapeutics, Inc. entered into an asset purchase agreement to acquire Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey from Progenics Pharmaceuticals, Inc. for $8 million.
CI
International Isotopes Inc. Terminates Manufacturing and Supply Agreement with Progenics Pharmaceuticals, Inc
CI
Lantheus Holdings, Inc., Progenics Pharmaceuticals, Inc., and Exini Diagnostics AB Announces U.S. Food and Drug Administration Clearance for Ai-Enabled Automated Bone Scan Index in Prostate Cancer on GE Healthcare’S Xeleris Platform
CI
PROGENICS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Progenics Pharmaceuticals, Inc. Announces Board Changes
CI
Progenics Pharmaceuticals, Inc. Announces Executive Changes
CI
Progenics Pharmaceuticals, Inc. Announces Executive Changes
CI
Progenics Pharmaceuticals, Inc. Appoints Robert J. Marshall Jr. as Treasurer
CI
Progenics Pharmaceuticals : Lantheus Completes Merger with Progenics
BU
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Composite 1500
CI
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600
CI
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 1000
CI
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P TMI Index
CI
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Global BMI Index
CI
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600 Health Care
CI
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Biotechnology Select Industry Index
CI
Lantheus Holdings, Inc. completed the acquisition of Progenics Pharmaceuticals, Inc. from Velan Capital, L.P., Virinder Nohria, LTE Partners, LLC, Terence Cooke, Gérard Ber and others.
CI
PROGENICS PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Progenics Pharmaceuticals, Inc.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW